Hofseth Biocare ASA Cash Flow Conversion Efficiency

Latest as of September 2025: 0.167x

Hofseth Biocare ASA cash flow conversion efficiency. Based on the latest financial reports, Hofseth Biocare ASA (HBC) has a cash flow conversion efficiency ratio of 0.167x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-4.65 Million ≈ $-489.52K USD) by net assets (Nkr-27.85 Million ≈ $-2.93 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Hofseth Biocare ASA (2010–2024)

Cash flow conversion efficiency of Hofseth Biocare ASA from 2010 to 2024. This chart illustrates how Hofseth Biocare ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Hofseth Biocare ASA for real-time trading data and today's change.

Hofseth Biocare ASA Cash Flow Conversion Ratio Explained

Hofseth Biocare ASA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Hofseth Biocare ASA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hofseth Biocare ASA ranked by their cash flow conversion efficiency. Also see how much is Hofseth Biocare ASA worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Nevada King Gold Corp V:NKG	-0.095x
Asia Pacific Wire & Cable Corp Ltd NASDAQ:APWC	-0.066x
Kentucky First Federal Bancorp NASDAQ:KFFB	0.018x
LAVA Therapeutics NV NASDAQ:LVTX	-0.384x
Spectral AI Inc. NASDAQ:MDAI	0.305x
Primotec Group Ltd TA:PRMG	0.071x
YES24 Co.Ltd KQ:053280	0.014x
Li Cheng Enterprise Co Ltd TW:4426	-0.022x

Annual Cash Flow Conversion Efficiency for Hofseth Biocare ASA (2010–2024)

The table below shows the annual cash flow conversion efficiency of Hofseth Biocare ASA from 2010 to 2024. Review Hofseth Biocare ASA (HBC) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Nkr61.30 Million ≈ $6.45 Million	Nkr-9.78 Million ≈ $-1.03 Million	-0.160x	-337.71%
2023-12-31	Nkr41.14 Million ≈ $4.33 Million	Nkr2.76 Million ≈ $290.54K	0.067x	+121.99%
2022-12-31	Nkr148.03 Million ≈ $15.58 Million	Nkr-45.17 Million ≈ $-4.75 Million	-0.305x	+30.67%
2021-12-31	Nkr140.38 Million ≈ $14.77 Million	Nkr-61.78 Million ≈ $-6.50 Million	-0.440x	-88.34%
2020-12-31	Nkr263.76 Million ≈ $27.76 Million	Nkr-61.63 Million ≈ $-6.49 Million	-0.234x	+11.42%
2019-12-31	Nkr117.75 Million ≈ $12.39 Million	Nkr-31.06 Million ≈ $-3.27 Million	-0.264x	+20.71%
2018-12-31	Nkr86.04 Million ≈ $9.05 Million	Nkr-28.62 Million ≈ $-3.01 Million	-0.333x	+51.59%
2017-12-31	Nkr37.08 Million ≈ $3.90 Million	Nkr-25.48 Million ≈ $-2.68 Million	-0.687x	+45.24%
2016-12-31	Nkr53.56 Million ≈ $5.64 Million	Nkr-67.23 Million ≈ $-7.07 Million	-1.255x	-612.71%
2015-12-31	Nkr32.55 Million ≈ $3.42 Million	Nkr7.97 Million ≈ $838.36K	0.245x	+131.04%
2014-12-31	Nkr78.95 Million ≈ $8.31 Million	Nkr-62.26 Million ≈ $-6.55 Million	-0.789x	+41.55%
2013-12-31	Nkr62.00 Million ≈ $6.52 Million	Nkr-83.65 Million ≈ $-8.80 Million	-1.349x	-34.11%
2012-12-31	Nkr47.72 Million ≈ $5.02 Million	Nkr-48.01 Million ≈ $-5.05 Million	-1.006x	-522.78%
2011-12-31	Nkr120.53 Million ≈ $12.68 Million	Nkr-19.47 Million ≈ $-2.05 Million	-0.162x	+1.39%
2010-12-31	Nkr75.97 Million ≈ $7.99 Million	Nkr-12.45 Million ≈ $-1.31 Million	-0.164x	--

About Hofseth Biocare ASA

OL:HBC Norway Packaged Foods

Market Cap

$45.73 Million

Nkr434.58 Million NOK

Market Cap Rank

#21987 Global

#201 in Norway

Share Price

Nkr1.10

Change (1 day)

+0.92%

52-Week Range

Nkr1.09 - Nkr1.90

All Time High

Nkr10.95